Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$40.39M+313%-$18.98M+28.5%-$26.57M+2.7%
$9.55M+16.7%$8.19M+22.0%$6.71M+6.8%$6.28M+3.6%$6.07M+1.7%
$18.65M+4.6%$17.83M+13.1%$15.77M-19.1%$19.49M-1.5%$19.79M-0.5%
-$44.78M+8.4%-$48.91M-15.5%-$42.36M
$12.16M+26.7%$9.6M-22.1%$12.32M-34.5%$18.8M-42.4%$32.66M+5.8%
$74.07M+6.2%$69.75M
-$5.53M+38.0%-$8.91M+19.3%-$11.04M-10.6%-$9.99M+0.7%-$10.06M-74.7%
$31.95M+1,447%-$2.37M+74.7%
-$56.94M+2.7%-$58.51M-7.0%-$54.68M-212%-$17.51M+11.9%-$19.87M+40.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Strata Critical Medical, Inc. Class A Common Stock generate?
Strata Critical Medical, Inc. Class A Common Stock (SRTA) generated -$44.8M in operating cash flow over the trailing twelve months.
What is Strata Critical Medical, Inc. Class A Common Stock's free cash flow?
After $12.2M of capital expenditures, Strata Critical Medical, Inc. Class A Common Stock's free cash flow was -$56.9M over the trailing twelve months, down 186.5% year over year.
Where does Strata Critical Medical, Inc. Class A Common Stock's cash flow data come from?
Every line is extracted from Strata Critical Medical, Inc. Class A Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.